NCT05108519 Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies
| NCT ID | NCT05108519 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Hematopoietic and Lymphoid Cell Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 170 participants |
| Start Date | 2019-04-08 |
| Primary Completion | 2027-02-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 170 participants in total. It began in 2019-04-08 with a primary completion date of 2027-02-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study collects information about complications and clinical response in cancer patients treated with anti-VEGF-related therapies. This study aims to observe side effects that may happen to patients with advanced cancer who are treated with anti-VEGF related therapy. This may help doctors learn if there are any relationships between these side effects and how the disease may respond to treatment.
Eligibility Criteria
Inclusion Criteria: * Patients must be able to understand and be willing to sign a written informed consent document * Patients must be receiving any anti-VEGF-related regimen in monotherapy or combination therapy
Contact & Investigator
Nicolas L Palaskas
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT05108519 clinical trial?
This trial is open to participants of all sexes, studying Hematopoietic and Lymphoid Cell Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05108519 currently recruiting?
Yes, NCT05108519 is actively recruiting participants. Visit ClinicalTrials.gov or contact M.D. Anderson Cancer Center to inquire about joining.
Where is the NCT05108519 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT05108519 clinical trial?
NCT05108519 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Nicolas L Palaskas at M.D. Anderson Cancer Center. The trial plans to enroll 170 participants.